Structural insights into human MHC-II association with invariant chain.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
07 May 2024
Historique:
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 30 4 2024
Statut: ppublish

Résumé

The loading of processed peptides on to major histocompatibility complex II (MHC-II) molecules for recognition by T cells is vital to cell-mediated adaptive immunity. As part of this process, MHC-II associates with the invariant chain (Ii) during biosynthesis in the endoplasmic reticulum to prevent premature peptide loading and to serve as a scaffold for subsequent proteolytic processing into MHC-II-CLIP. Cryo-electron microscopy structures of full-length Human Leukocyte Antigen-DR (HLA-DR) and HLA-DQ complexes associated with Ii, resolved at 3.0 to 3.1 Å, elucidate the trimeric assembly of the HLA/Ii complex and define atomic-level interactions between HLA, Ii transmembrane domains, loop domains, and class II-associated invariant chain peptides (CLIP). Together with previous structures of MHC-II peptide loading intermediates DO and DM, our findings complete the structural path governing class II antigen presentation.

Identifiants

pubmed: 38687785
doi: 10.1073/pnas.2403031121
doi:

Substances chimiques

invariant chain 0
Antigens, Differentiation, B-Lymphocyte 0
Histocompatibility Antigens Class II 0
HLA-DR Antigens 0
HLA-DQ Antigens 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2403031121

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI103867
Pays : United States

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Nan Wang (N)

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
HHMI, Stanford University School of Medicine, Stanford, CA 94305.

Deepa Waghray (D)

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.

Nathanael A Caveney (NA)

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.

Kevin M Jude (KM)

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
HHMI, Stanford University School of Medicine, Stanford, CA 94305.

K Christopher Garcia (KC)

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
HHMI, Stanford University School of Medicine, Stanford, CA 94305.
Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH